Gan To Provide Sports Betting Infrastructure For Red Rock Resorts
Gan Ltd (NASDAQ:GAN) has signed an agreement with Red Rock Resorts Inc (Station Casinos) to power retail and online race & sports…
GAN Says Co’s Technology Platform Now Helping To Deliver FanDuel iGaming In Connecticut
https://investors.gan.com/websites/gan/English/2110/news-detail.html?airportNewsID=ee9e476f-2dfd-401a-a77e-241303e7fb18
GAN To Host Investor Event in Las Vegas, Nevada On Oct. 4, 2021
GAN's executive leadership team to provide insight into the Company's business opportunities and long-term outlook
GAN Limited (the "Company" or "GAN") (NASDAQ:GAN), a leading
66 Biggest Movers From Yesterday
Gainers
Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares surged 265.5% to close at $15.35 on Tuesday after the company received a written pre-investigational new drug (pre-IND) response from the FDA regarding MMS019.
Gan Shares Plummet After Mixed Q2 Results
Gan Ltd (NASDAQ:GAN) reported second-quarter FY21 revenue growth of 316% year-on-year, to $34.63 million, beating the analyst consensus of $31.88 million. Revenue…
48 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares jumped 93% to $$8.10 after the company received a written pre-investigational new drug (pre-IND) response from the FDA regarding MMS019.
GAN Q2 EPS $(0.07) Misses $(0.05) Estimate, Sales $34.60M Beat $31.88M Estimate
GAN (NASDAQ:GAN) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.05) by 40 percent. This is a 69.57 percent increase over losses of $(0.23) per share from the same period
Earnings Scheduled For August 16, 2021
Companies Reporting Before The Bell
• Entera Bio (NASDAQ:ENTX) is likely to report earnings for its second quarter.
• Data Storage (NASDAQ:DTST) is expected to report earnings for its second quarter.
Growth In B2B, B2C To Power GAN Ahead: Analyst
A company that provides the technology for sports betting and iGaming companies saw new analyst coverage Tuesday.
The GAN Analyst: Jefferies analyst David Katz is initiating coverage on GAN Limited (NASDAQ: GAN) with a Buy rating and $21 price target.